ABT
ABBOTT LABORATORIES · Healthcare · Market cap $180.8B
Insiders sold $46.7M net in the last 90 days ·3 sellers, 1 buyer· latest Form 4 filed Sep 3, 2026
Insider Buying
$4.4M
reported purchases (SEC code P)
Insider Selling
$47.5M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Sep 3, 2026
MCCOY JOHN A. JR.
ABBOTT LABORATORIES (ABT) has 45 SEC Form 4 filings (57 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 10 insiders at ABBOTT LABORATORIES reported 5 open-market purchases totaling $4.4M and 10 open-market sales totaling $47.5M. Insiders have net sold $45.5M over the trailing 6 months. The most recent open-market filing is a sale of 27 shares by VICE PRESIDENT AND CONTROLLER MCCOY JOHN A. JR., dated Sep 2, 2026, worth $3K.
- Industry:Medical - Devices
- CEO:Robert Ford
- Employees:115,000
- HQ:Abbott Park, IL, US
- IPO:1980-03-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
MCCOY JOHN A. JR.First in 6 months | VICE PRESIDENT AND CONTROLLER | Sale | 27 | $3K | Sep 3 | -4.9% | SEC ↗ |
Ford Robert BFirst in 7 months | CHAIRMAN AND CEO | Sale | 398,832 | $46.2M | Aug 27 | -7.3% | SEC ↗ |
Morrone Louis H.First in 5 months | EXECUTIVE VICE PRESIDENT | Sale | 5,850 | $643K | Aug 13 | -7.0% | SEC ↗ |
Stratton John GFirst filing | Director | Purchase | 2,000 | $174K | Jun 18 | +17.1% | SEC ↗ |
| Insider | Purchase | 10,000 | $927K | Apr 28 | +10.3% | SEC ↗ | |
Boudreau Philip PFirst filing | EVP AND CFO | Purchase | 2,200 | $201K | Apr 27 | +11.5% | SEC ↗ |
Shroff EricFirst in 3 months | Senior Vice President | Sale | 709 | $82K | Mar 3 | -8.9% | SEC ↗ |
Cushman Elizabeth C.First filing | EVP, GC AND SECRETARY | Sale | 263 | $30K | Mar 3 | -8.9% | SEC ↗ |
Salvadori Daniel Gesua SiveFirst filing | EVP AND GROUP PRESIDENT | Sale | 885 | $102K | Mar 3 | -8.9% | SEC ↗ |
Moreland Mary KFirst filing | EXECUTIVE VICE PRESIDENT | Sale | 613 | $71K | Mar 3 | — | SEC ↗ |
MCCOY JOHN A. JR.First filing | VICE PRESIDENT AND CONTROLLER | Sale | 585 | $68K | Mar 3 | — | SEC ↗ |
Morrone Louis H.First filing | EXECUTIVE VICE PRESIDENT | Sale | 1,144 | $132K | Mar 3 | — | SEC ↗ |
STARKS DANIEL JFirst filing | Director | Purchase | 10,000 | $1.1M | Feb 6 | — | SEC ↗ |
Ford Robert BFirst filing | CHAIRMAN AND CEO | Purchase | 18,800 | $2.0M | Jan 26 | — | SEC ↗ |
Shroff EricFirst filing | Senior Vice President | Sale | 1,586 | $203K | Nov 25 | — | SEC ↗ |
Congress trading ABT 204 all-time
- RRep. Richard W. AllenSale$15,001 - $50,0002026-07-14
- RRep. Rick W. AllenSale$15,001 - $50,0002026-07-14
- RRep. Rich McCormickSale$1,001 - $15,0002026-07-30
- RRep. Mike KellySale$1,001 - $15,0002026-07-17
- DRep. Rick LarsenSale$1,001 - $15,0002026-07-08
- DRep. Richard Ray LarsenSale$1,001 - $15,0002026-07-08
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ABT have?
ABBOTT LABORATORIES (ABT) has 45 SEC Form 4 filings (57 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for ABT?
The most recent Form 4 filing for ABT on Tracefour is dated Sep 3, 2026.
What is the net insider flow at ABT over the last 6 months?
Over the trailing 180 days, insiders at ABT have net sold $45.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ABT in the current window?
Inside the rolling window, insiders at ABT bought $4.4M and sold $47.5M based on SEC Form 4 filings.
Can I get alerts for ABT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ABBOTT LABORATORIES (ABT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ABBOTT LABORATORIES is in the Healthcare sector.